Compile Data Set for Download or QSAR
Report error Found 11 Enz. Inhib. hit(s) with all data for entry = 11928
TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM661386(US20240101566, Compound 18)
Affinity DataIC50: 3.98nMAssay Description:Experimental Reagents: Reagent Vendor Cat No.Recombinant Human His6-USP1/His6-UAF1 R&D E-568-050Complex ProteinUbiquitin Rhodamine 110 Protein, CF (U...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM661387(US20240101566, Compound 19)
Affinity DataIC50: 4.36nMAssay Description:Experimental Reagents: Reagent Vendor Cat No.Recombinant Human His6-USP1/His6-UAF1 R&D E-568-050Complex ProteinUbiquitin Rhodamine 110 Protein, CF (U...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM661382(US20240101566, Compound 2)
Affinity DataIC50: 5nMAssay Description:Experimental Reagents: Reagent Vendor Cat No.Recombinant Human His6-USP1/His6-UAF1 R&D E-568-050Complex ProteinUbiquitin Rhodamine 110 Protein, CF (U...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM661391(US20240101566, Compound 17-1)
Affinity DataIC50: 6.66nMAssay Description:Experimental Reagents: Reagent Vendor Cat No.Recombinant Human His6-USP1/His6-UAF1 R&D E-568-050Complex ProteinUbiquitin Rhodamine 110 Protein, CF (U...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM661385(US20240101566, Compound 16 | US20240101566, Compou...)
Affinity DataIC50: 6.67nMAssay Description:Experimental Reagents: Reagent Vendor Cat No.Recombinant Human His6-USP1/His6-UAF1 R&D E-568-050Complex ProteinUbiquitin Rhodamine 110 Protein, CF (U...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM661385(US20240101566, Compound 16 | US20240101566, Compou...)
Affinity DataIC50: 8nMAssay Description:Experimental Reagents: Reagent Vendor Cat No.Recombinant Human His6-USP1/His6-UAF1 R&D E-568-050Complex ProteinUbiquitin Rhodamine 110 Protein, CF (U...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM661373(US20240101566, Compound 1 | US20240101566, Compoun...)
Affinity DataIC50: 12.9nMAssay Description:Experimental Reagents: Reagent Vendor Cat No.Recombinant Human His6-USP1/His6-UAF1 R&D E-568-050Complex ProteinUbiquitin Rhodamine 110 Protein, CF (U...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM661389(US20240101566, Compound 11-1)
Affinity DataIC50: 15nMAssay Description:Experimental Reagents: Reagent Vendor Cat No.Recombinant Human His6-USP1/His6-UAF1 R&D E-568-050Complex ProteinUbiquitin Rhodamine 110 Protein, CF (U...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM661383(US20240101566, Compound 3)
Affinity DataIC50: 18nMAssay Description:Experimental Reagents: Reagent Vendor Cat No.Recombinant Human His6-USP1/His6-UAF1 R&D E-568-050Complex ProteinUbiquitin Rhodamine 110 Protein, CF (U...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM661384(US20240101566, Compound 11)
Affinity DataIC50: 22nMAssay Description:Experimental Reagents: Reagent Vendor Cat No.Recombinant Human His6-USP1/His6-UAF1 R&D E-568-050Complex ProteinUbiquitin Rhodamine 110 Protein, CF (U...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent

TargetUbiquitin carboxyl-terminal hydrolase 1(Human)
Shandong Xuanzhu Pharma Co.

US Patent
LigandPNGBDBM661373(US20240101566, Compound 1 | US20240101566, Compoun...)
Affinity DataIC50: 28nMAssay Description:Experimental Reagents: Reagent Vendor Cat No.Recombinant Human His6-USP1/His6-UAF1 R&D E-568-050Complex ProteinUbiquitin Rhodamine 110 Protein, CF (U...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2024
Entry Details
Go to US Patent